HomeCompareCCPPF vs JNJ

CCPPF vs JNJ: Dividend Comparison 2026

CCPPF yields 2.84% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CCPPF wins by $319.27M in total portfolio value
10 years
CCPPF
CCPPF
● Live price
2.84%
Share price
$1.75
Annual div
$0.05
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$319.30M
Annual income
$299,085,554.21
Full CCPPF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CCPPF vs JNJ

📍 CCPPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCCPPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CCPPF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CCPPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CCPPF
Annual income on $10K today (after 15% tax)
$241.60/yr
After 10yr DRIP, annual income (after tax)
$254,222,721.08/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, CCPPF beats the other by $254,218,683.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CCPPF + JNJ for your $10,000?

CCPPF: 50%JNJ: 50%
100% JNJ50/50100% CCPPF
Portfolio after 10yr
$159.67M
Annual income
$149,545,152.04/yr
Blended yield
93.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CCPPF
No analyst data
Altman Z
2.2
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CCPPF buys
0
JNJ buys
0
No recent congressional trades found for CCPPF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCCPPFJNJ
Forward yield2.84%2.14%
Annual dividend / share$0.05$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$319.30M$30.5K
Annual income after 10y$299,085,554.21$4,749.88
Total dividends collected$317.79M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CCPPF vs JNJ ($10,000, DRIP)

YearCCPPF PortfolioCCPPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,268$568.46$10,594$274.49+$674.00CCPPF
2$13,255$1,197.33$11,294$360.69+$2.0KCCPPF
3$16,815$2,632.46$12,133$476.91+$4.7KCCPPF
4$24,234$6,242.15$13,156$635.42+$11.1KCCPPF
5$42,746$16,815.65$14,432$854.61+$28.3KCCPPF
6$101,179$55,440.87$16,056$1,162.76+$85.1KCCPPF
7$353,547$245,285.04$18,175$1,604.53+$335.4KCCPPF
8$1,980,334$1,602,038.61$21,009$2,252.68+$1.96MCCPPF
9$18,891,955$16,772,997.77$24,911$3,229.73+$18.87MCCPPF
10$319,299,946$299,085,554.21$30,458$4,749.88+$319.27MCCPPF

CCPPF vs JNJ: Complete Analysis 2026

CCPPFStock

Shaftesbury Capital PLC (Shaftesbury Capital) is the leading central London mixed-use REIT and is a constituent of the FTSE-250 Index. Our property portfolio, valued at £4.9 billion at June 2023, extends to 2.9 million square feet of lettable space across the most vibrant areas of London's West End. With a diverse mix of restaurants, cafés, bars, shops, residential and offices, our destinations include the high footfall, thriving neighbourhoods of Covent Garden, Carnaby, Soho and Chinatown, together with holdings in Fitzrovia. Our properties are close to the main West End Underground stations and transport hubs for the Elizabeth Line. Shaftesbury Capital shares are listed on the London Stock Exchange (primary) and the Johannesburg Stock Exchange (secondary).

Full CCPPF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CCPPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CCPPF vs SCHDCCPPF vs JEPICCPPF vs OCCPPF vs KOCCPPF vs MAINCCPPF vs ABBVCCPPF vs MRKCCPPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.